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a b s t r a c t 
Blood–brain barrier disruption represents a key feature in hyperglycaemia-aggravated cerebral damage after 
an ischaemic stroke. Although the underlying mechanisms remain largely unknown, activation of protein 
kinase C (PKC) is thought to play a critical role. This study examined whether apoptosis of human brain
microvascular endothelial cells (HBMEC) might contribute to hyperglycaemia-evoked barrier damage and 
assessed the speciﬁc role of PKC in this phenomenon. Treatments with hyperglycaemia (25 mM) or phor- 
bol myristate acetate (PMA, a protein kinase C activator, 100 nM) signiﬁcantly increased NADPH oxidase 
activity, O 2 
•− generation, proapoptotic protein Bax expression, TUNEL-positive staining and caspase-3 / 7 
activities. Pharmacological inhibition of NADPH oxidase, PKC- α, PKC- β or PKC- βI via their speciﬁc inhibitors 
and neutralisation of O 2 
•− by a cell-permeable superoxide dismutase mimetic, MnTBAP normalised all the 
aforementioned increases induced by hyperglycaemia. Suppression of these PKC isoforms also negated the 
stimulatory effects of hyperglycaemia on the protein expression of NADPH oxidase membrane-bound compo- 
nents, Nox2 and p22-phox which determine the overall enzymatic activity. Silencing of PKC- βI gene through 
use of speciﬁc siRNAs abolished the effects of both hyperglycaemia and PMA on endothelial cell NADPH 
oxidase activity, O 2 
•− production and apoptosis and consequently improved the integrity and function of 
an in vitro model of human cerebral barrier comprising HBMEC, astrocytes and pericytes. Hyperglycaemia- 
mediated apoptosis of HBMEC contributes to cerebral barrier dysfunction and is modulated by sequential 
activations of PKC- βI and NADPH oxidase. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). ntroduction 
Diabetes and acute stress hyperglycaemia increase the rates of 
ortality and morbidity in patients with ischaemic stroke by exac- 
rbating the breakdown of blood–brain barrier (BBB) [ 1 ]. Endothe- 
ial cells cover the entire inner surface of all blood vessels and help 
orm the BBB in the central nervous system to prevent the entry of 
irculating molecules into the brain parenchyma. Anomalies in pro- 
rammed death (apoptosis) of cells which make up the BBB, especially 
hat of brain microvascular endothelial cells (BMEC), may represent a 
ey phenomenon in hyperglycaemia-evoked BBB disruption. Indeed, 
he apoptotic effect of hyperglycaemia on endothelial cells derived 
rom large arteries and venous system e.g. aorta and umbilical vein 
s well-documented [ 2 , 3 ]. Although the mechanisms involved remain 
nclear, hyperglycaemia is known to elicit cellular injury by increas- 
ng the quantities of pro-apoptotic proteins (Bad, Bax and Bid) and * Correspondence to: Stroke, Division of Clinical Neuroscience, Clinical Sciences 
uilding, Hucknall Road, Nottingham NG5 1PB, UK. 
E-mail address: ulvi.bayraktutan@nottingham.ac.uk (U. Bayraktutan). 
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ttp://dx.doi.org/10.1016/j.redox.2014.05.005 possibly by decreasing those of anti-apoptotic bcl-2 proteins (Bcl-2 
and bcl-XL) [ 4 ]. Sufﬁcient elevations in Bax to Bcl-2 ratio in turn trig- 
ger the conversion of inactive procaspase-3 to caspase-3, the major 
executor of apoptotic process [ 3 ]. 
Hyperglycaemia can also induce apoptosis through stimulation of 
oxidative stress characterised by the exaggerated synthesis or release 
of free radicals, in particular superoxide anion (O 2 
•−) [ 5 , 6 ]. Higher 
concentrations of O 2 
•− may mediate the rates of endothelial cell apop- 
tosis through activation of a variety of redox-sensitive mechanisms 
including mitochondrial dysfunction, Bax protein overexpression and 
p38 mitogen-activated protein kinase (p38MAPK) [ 3 , 4 , 7 ]. As the main 
source of O 2 
•− in vasculature, NADPH oxidase is anticipated to be in- 
timately involved in BMEC survival / death [ 8 , 9 ]. 
Hyperglycaemia-mediated activation of protein kinase C (PKC) 
is regarded as a key step in peripheral and cerebral vasculopathies 
where activation of different PKC isoforms, particularly PKC- β is cou- 
pled to diabetes-induced endothelial dysfunction and neurovascu- 
lar complications [ 10 , 11 ]. Besides PKC- β, activations of other PKC 
isoforms have also been shown to induce apoptosis through utilisa- 
tion of different downstream effectors. For instance, stimulation of  open access article under the CC BY-NC-ND license ( http: // creativecommons.org / 


















































































 p38 αMAPK by PKC- δ and NADPH oxidase-mediated O 2 •− production
by PKC- βII have been shown to account for hyperglycaemia- and TNF-
α-induced apoptosis of bovine retinal pericytes and human umbilical
vein endothelial cells, respectively [ 6 , 12 ]. 
In light of the above, the aims of the current study were three-
fold. Firstly, it was to investigate whether and to what extent hy-
perglycaemia could compromise BMEC apoptosis. Secondly, it was to
determine if activation of PKC compromised BMEC viability in a com-
parable manner. Finally, it was to assess whether inhibition of PKC- βI
might prevent cells from undergoing apoptosis and thus protect BBB
integrity. 
Materials and methods 
Cell culture 
Human BMEC (HBMEC) (TCS Cellworks Ltd., Buckingham, UK), be-
tween passages 4 and 7, were cultured to almost 70% conﬂuence in its
specialised media before exposure to normoglycaemia (NG; 5.5 mM
d -glucose), hyperglycaemia (HG; 25 mM d -glucose) or d -mannitol
(5.5 mM d -glucose + 19.5 mM d -mannitol) for 72 h. The relevance of
individual PKC isoforms to hyperglycaemia-mediated particular out-
comes was investigated through simultaneous application of speciﬁc
inhibitors for PKC- α(Ro-32-0432, 1 μM), PKC- β (LY333531, 0.05 μM)
or PKC- βII (CGP53353, 1 μM) with hyperglycaemia for 72 h. Potential
contribution of O 2 
•− (MnTBAP, 2.5 μM), NADPH oxidase (apocynin,
1 mM), nitric oxide synthase (l-NAME, 100 μM), xanthine oxidase (al-
lopurinol, 100 μM), mitochondrial complex I (rotenone, 2 μM) and
cyclooxygenase (indomethacin, 50 μM) to hyperglycaemia-related
changes was also studied in similar conditions using speciﬁc in-
hibitors indicated in parentheses. 
To ascertain the speciﬁc role of PKC activation in the outlined
parameters, in some experiments HBMEC were treated with a PKC
activator, phorbol myristate acetate (PMA, 0.1 μM) for 4 h. 
TUNEL staining 
This is performed for detection and quantiﬁcation of apoptosis at
a single cell level, based on in situ labelling of fragmented DNA by the
DeadEnd colourimetric TUNEL system (Promega, WI, USA). Apoptotic
cells, characterised by dark brown staining, were then counted via
light microscopy. 
Caspase-3 / 7 assay 
In view of the roles of the caspase family members in mammalian
cell apoptosis, the activities of caspase-3 / 7 were also measured in HB-
MEC exposed to different experimental conditions using the Apo-ONE
homogeneous caspase-3 / 7 assay kit (Promega). Brieﬂy, onto HBMEC
grown in 96-well opaque black plates, 100 μl of diluted caspase-3 / 7
proﬂuorescent substrate were added. The mixture was incubated at
room temperature for 2 h and the enzymatic activities were assessed
using a ﬂuorescent plate reader. 
Establishment of an in vitro model of human BBB 
A triple-culture model of human BBB was set up. For this, human
astrocytes were seeded onto the outer surface of Transwell inserts
(12 mm diameter, 0.4 μm pore size; Corning Costar, High Wycombe,
UK) directed upside down. On the following day, the inserts were
inverted the correct way and placed into 12-well culture plates con-
taining human pericytes. HBMEC were then seeded onto the inner
side of the inserts before culturing all cell layers to conﬂuence. Analyses of the BBB characteristics 
The integrity and function of the BBB were evaluated as previously
described by transendothelial electrical resistance and the ﬂux of high
(Evan’s Blue-labelled albumin, 67 kDa) and low (sodium ﬂuorescein,
376 Da) molecular weight permeability markers, respectively [ 13 ]. 
Western blotting 
Equal amounts of total cellular proteins ( ∼40 μg) were run on
10–15% sodium dodecyl sulphate-polyacrylamide gels before trans-
ferring onto polyvinylidene ﬂuoride membranes and successively in-
cubating with a combination of β-actin (reference protein, Sigma
Aldrich, Poole, UK) and anti-Bax (Cell Signalling Technology, Danvers,
MA, USA), Nox2, PKC- βI (Santa Cruz, Dallas, Texas, USA) or p22-phox
(Abcam, Cambridge, UK) primary antibodies and appropriate infrared
dye-conjugated secondary antibodies (Li-Cor Biosci, Cambridge, UK).
Blots were analysed by densitometry using the Li-Cor Odyssey in-
frared imaging system. 
Measurements of O 2 
− production and NADPH oxidase activity 
The level of O 2 
•− production was measured by cytochrome C re-
duction as previously described [ 8 , 14 ]. In brief, cell pellets were son-
icated in cold lysis buffer containing 20 mM HEPES buffer (pH 7.2),
1 mM EGTA, 210 mM mannitol and 70 mM sucrose. Equal amounts of
homogenate (50 μl) were then incubated with 50 μM cytochrome C
for 60 min at 37 ◦C. O 2 •− generation was measured as the reduction of
cytochrome C and monitored as the change in absorbance at 550 nm
using a FLUOstar Omega plate reader (BMG, Aylesbury, UK). 
NAD(P)H oxidase activity was measured by the lucigenin chemi-
luminescence assay. HBMEC homogenates (50 μl) were incubated at
37 ◦C with assay buffer (50 mM potassium phosphate buffer (pH 7.0),
1 mM EGTA, 150 mM sucrose, and 5 μM lucigenin) containing the spe-
ciﬁc inhibitors of enzymes that are known to generate reactive oxy-
gen species (ROS), namely nitric oxide synthase (l-NAME, 100 μM),
xanthine oxidase (allopurinol, 100 μM), mitochondrial complex I
(rotenone, 50 μM) and cyclooxygenase (indomethacin, 50 μM). After
15 min NADPH (100 μM; Sigma Aldrich, Poole, UK) was added to ini-
tiate the reaction. The reaction was monitored every minute for 4 h
and the rate of reaction calculated. Buffer blanks were also run for
both assays and subtracted from the data. 
Small interfering RNA knockdown 
Semi-conﬂuent HBMEC were transfected for 24 h with Dharma-
FECT small interfering RNA (siRNA) transfection reagent 4 containing
50 nM of ON-TARGET plus SMART pool human siRNA against PKC- βI
(Thermo Scientiﬁc Dharmacon, Lafayette, CO, USA). HBMEC trans-
fected with non-targeting pool of siRNA served as controls. After ex-
posure to different experimental conditions, HBMEC were harvested
for different assays. 
Statistical analysis 
Data are presented as mean ± SEM. Statistical analyses were per-
formed using GraphPad Prism 6.0 statistical software package. Data
were analysed by nonparametric Mann–Whitney U test or one-way
ANOVA followed by Dunnett’s post-hoc analyses, where appropriate.
P < 0.05 was considered signiﬁcant. 



















































Fig. 1. (A) Effects of speciﬁc inhibitors targeting the main free radical-generating en- 
zymes and protein kinase C (PKC)- α, PKC- β and PKC- βII isoforms on O 2 •− production 
( n ≥ 3) in human brain microvascular endothelial cells (HBMEC) subjected to hyper- 
glycaemia (HG; 25 mM d -glucose) for 72 h. Effects of inhibitors for PKC- α, PKC- β and 
PKC- βII on gp91-phox( n = 3) (B) and p22-phox ( n = 3) (C) protein expressions in 
HBMEC exposed to HG. Data are expressed as mean ± SEM. * P < 0.05 versus normo- 
glycaemia (NG), + P < 0.05 versus HG. esults 
yperglycaemia evokes oxidative stress in endothelial cells via 
ctivation of NADPH oxidase 
Exposure of HBMEC to hyperglycaemia led to a signiﬁcant increase 
n total O 2 
•− generation which was normalised by speciﬁc inhibition 
f NADPH oxidase, PKC- α, PKC- β and PKC- βII but not those of ni- 
ric oxide synthase, mitochondrial complex I, cyclooxygenase or xan- 
hine oxidase. Treatment of HBMEC with a potent free radical scav- 
nger, MnTBAP almost completely abolished the hyperglycaemia- 
voked O 2 
•− generation. Inhibition of the aforementioned PKC iso- 
orms negated hyperglycaemia-mediated increases observed in pro- 
ein expressions of NADPH oxidase membrane-bound components, 
amely p22-phox and Nox2 which determine enzymatic activity and 
tability as a whole ( Fig. 1 A–C). 
yperglycaemia promotes endothelial cell apoptosis through NADPH 
xidase and PKC activations 
Hyperglycaemia signiﬁcantly increased TUNEL-positive staining 
DNA fragmentation), caspase-3 / 7 activities and Bax protein expres- 
ion in HBMEC which appeared to be independent of hyperglycaemia- 
ediated increases in osmolality. Inhibition of NADPH oxidase, PKC- 
, PKC- β and PKC- βII and neutralisation of O 2 •− effectively sup- 
ressed all the increases observed in the apoptotic parameters. How- 
ver, reductions in DNA fragmentation rates stayed signiﬁcantly 
igher in MnTBAP-treated cells compared to controls ( Fig. 2 A–E). 
nduction of PKC promotes endothelial cell apoptosis 
To determine whether elevations in PKC activity during a hyper- 
lycaemic insult may constitute the main cause of apoptosis, in some 
xperiments the PKC activity was increased by exposing HBMEC to 
ncreasing concentrations of PMA (0.1–1 μM) for 2–4 h. As these 
evealed time-dependent increases in total PKC activity, in subse- 
uent studies the cells were treated with 0.1 μM of PMA for 4 h 
hich produced signiﬁcant increases in PKC- βI activity and all apop- 
otic parameters i.e. DNA fragmentation rates, caspase-3 / 7 activi- 
ies and Bax protein expression ( Fig. 3 A–E). Silencing of PKC- βI gene 
ramatically diminished its protein expression and attenuated both 
yperglycaemia- and PMA-evoked increases observed in NADPH ox- 
dase activity and O 2 
•− production ( Fig. 4 A–E). 
uppression of PKC- β I prevents apoptosis and protects cerebral barrier 
Knockdown of PKC- βI also effectively suppressed both 
yperglycaemia-induced apoptosis as evidenced by radical decreases 
bserved in all apoptotic parameters ( Fig. 5 A–D). Although silenc- 
ng of PKC- βI gene neutralised PMA-mediated increases in apoptosis 
ate and Bax protein expression, it failed to normalise caspase-3 / 7 
ctivities ( Fig. 6 A–D). PKC- βI knockdown also negated the deleteri- 
us effects of both hyperglycaemia and PMA on cerebral barrier in- 
egrity and function as proven by marked increases in transendothe- 
ial electrical resistance and concurrent decreases in paracellular ﬂux 
f Evan’s Blue-labelled albumin and sodium ﬂuorescein, respectively 
 Fig. 7 A–C). 
iscussion 
Increased prevalence of BBB failure in stroke patients with dia- 
etes bestows a pivotal role on hyperglycaemia in the pathogenesis 
f this defect. However, the mechanisms involved remain ambigu- 
us and require in depth investigation in order to devise efﬁcacious 
ovel therapies to prevent barrier leakage. Using an in vitro model of human cerebral barrier, we have recently shown that hypergly- 
caemia compromises the structural and functional capacities of BBB 
through a mechanism involving concurrent activations of PKC- β and 
NADPH oxidase [ 14 ]. In light of this, the present study investigated 
whether putative increases in apoptosis of BMEC, the most promi- 
nent cellular component of the cerebral barrier, may also contribute 
to the hyperglycaemia-evoked BBB dysfunction and is affected by the 
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Fig. 2. Effects of inhibitors for NADPH oxidase (apocynin), superoxide anion (MnT- 
BAP) and protein kinase C- α (PKC- α), PKC- β and PKC- βII on (A) TUNEL staining (Bar, 
100 μm), (B) DNA fragmentation rates ( n ≥ 3), (C) caspase-3 / 7 activities ( n ≥ 3), (D, 
E) Bax protein expressions ( n = 4 and 3) in human brain microvascular endothelial 
cells (HBMEC) exposed to hyperglycaemia (HG; 25 mM d -glucose) for 72 h. Data are 

























Fig. 3. Effect of phorbol myristate acetate (PMA; 0.1–1 μM) on total protein kinase C 
(PKC) ( n = 4) (A) and PKC- βI ( n = 4) (B) activities in human brain microvascular en- 
dothelial cells (HBMEC). Effect of PMA (4 h, 100 nM) on HBMEC (C) DNA fragmentation 
( n ≥ 3), (D) caspase-3 / 7 activities ( n = 4) and (E) Bax protein expression ( n = 4). Data 
are expressed as mean ± SEM. * P < 0.05 versus normoglycaemia (NG). 
Fig. 4. Knockdown of protein kinase C (PKC)- βI gene normalises the effects of hyper- activities of PKC and / or NADPH oxidase. 
Accumulating evidence has displayed hyperglycaemia-mediated
apoptosis as one of the key mediators of vascular complications, such
as retinopathy, to which induction of NF- κB, c-jun NH 2 terminal ki-
nase, shp-1 and PKC- δ appear to contribute [ 12 , 15 ]. However, given
that endothelial cells derive from different parts of the vascular tree
respond to the effects of hyperglycaemia in a different manner, it was
important to ascertain whether and to what extent hyperglycaemia
alters BMEC viability and reveal the mechanisms involved [ 16 ]. To
this end, the present study shows that hyperglycaemia evokes sig-
niﬁcant increases in HBMEC apoptosis as evidenced by increases in
DNA fragmentation rates, caspase-3 / 7 activities and in expression
of proapoptotic protein Bax. Marked increases in Bax or Bax / Bcl-2
ratio have previously been linked to hyperglycaemia-mediated apop-
tosis of human aortic endothelial cells [ 3 ]. Hyperglycaemia-evoked
translocation of Bax protein into mitochondrial membrane leads to
disruption of mitochondrial membrane integrity thereby facilitating
the escape of cytochrome C from mitochondria and consequent acti-
vation of caspase-9 [ 3 , 17 ]. Caspase-9, in turn, activates several down-
stream caspases amongst which caspase-3 and caspase-7 were shown
to be of particular importance in HBMEC. 
Oxidative stress, associated with excessive availability of O 2 
•−
may account for hyperglycaemia-evoked apoptosis. Using speciﬁc
inhibitors of the major prooxidant enzymes, the current study has
shown NADPH oxidase as the main source of O 2 
•− in hyperglycaemic
endothelial cells. Indeed, speciﬁc inhibition of this oxidase protected
glycaemia (HG) (A, B) ( n = 3 and 4) and PMA (C, D) (both n = 3) on superoxide anion 
generation and NADPH oxidase activity and reduces PKC- βI protein expression ( n = 3) 
(E) in human brain microvascular endothelial cells. Data are expressed as mean ± SEM. 
* P < 0.05 versus normoglycaemia (NG), + P < 0.05 versus HG or PMA (4 h, 100 nM). 
698 B. Shao, U. Bayraktutan / Redox Biology 2 (2014) 694–701 
Fig. 5. Effect of protein kinase C- βI (PKC- βI ) gene knockdown on TUNEL staining (Bar, 
100 μm) (A), DNA fragmentation rates ( n = 3) (B), caspase-3 / 7 activities ( n ≥ 6) (C) 
and Bax protein expression ( n = 3) (D) in human brain microvascular endothelial cells 
exposed to hyperglycaemia (HG). Data are expressed as mean ± SEM. * P < 0.05 versus 
























Fig. 6. Effect of protein kinase C- βI (PKC- βI ) gene silencing on TUNEL staining (Bar, 
100 μm) (A), DNA fragmentation rates ( n = 3) (B), caspase-3 / 7 activities ( n ≥ 6) (C) 
and Bax protein expression ( n = 3) (D) in human brain microvascular endothelial cells 
exposed to PMA (100 nM) for 4 h. Data are expressed as mean ± SEM. * P < 0.05 versus 
normoglycaemia (NG), + P < 0.05 versus PMA. BMEC from apoptosis as evidenced by marked decreases in all apop- 
otic parameters. Interestingly, despite almost completely eradicat- 
ng the availability of O 2 
•−, MnTBAP, a cell-permeable superoxide 
ismutase mimetic failed to normalise HG-mediated elevations in 
NA fragmentation rates. Taken together, these data ascribe addi- 
ional beneﬁts to inhibition of vascular NADPH oxidase beyond its 
 2 
•−-related effects. 
NADPH oxidases make up a dedicated family of O 2 
•−-forming en- 
ymes. In general, they are activated by coupling of Nox2, the cat- 
lytic subunit, with other subunits, p22-phox, p47-phox, p40-phox 
nd p67-phox. Although seven isoforms of Nox have been identi- 
ed to date, only Nox1, Nox2, Nox4 and Nox5 are known to be ex- 
ressed in vascular cells [ 18 , 19 ]. In light of our past and present stud- 
es proving Nox2-derived O 2 
•− as the key regulator of blood–brain 
arrier integrity, endothelial function and microvascular endothelial 
ell growth, we speciﬁcally focused on this particular isoform in the 
urrent study [ 20 –23 ]. Discovery of considerably smaller cerebral in- 
arcts in Nox2-deﬁcient mice subjected to middle cerebral artery oc- 
lusion further corroborate the correlation between Nox2 availability 
nd cerebral homeostasis [ 24 ]. 
Despite constituting the main Nox isoform in colon epithelial cells, 
ox1 is also associated with production of low levels of O 2 
•− in 
asculature [ 25 , 26 ]. However, through a complex reaction involving 
oncomitant induction of PKC-, MAPK- and PKA-dependent mech- 
nisms, the vascular pathologies appear to elevate Nox1-mediated release of O 2 
•− [ 27 –29 ] which in turn may trigger BMEC apoptosis 
to elicit barrier permeability. In this context, the hyperglycaemia- 
evoked apoptosis of a murine BMEC line, bEnd3 has recently been 
attributed to NF- κB-dependent upregulation of p22-phox and Nox1 
isoforms. However, negation of apoptosis by agents that inhibit the 
activity of NADPH oxidase complex, namely apocynin and resveratrol, 
a polyphenolic antioxidant suggest the involvement of other Nox iso- 
forms, in particular Nox2, in this phenomenon [ 30 ]. 
Unlike other isoforms of Nox, Nox4 predominantly generates H 2 O 2 
[ 31 ]. As it is mainly implicated in cellular senescence and vascular and 
renal complications of diabetes, its inhibition, in various models of 
diabetes, has unsurprisingly led to reduced oxidative stress, inﬂam- 
mation and availability of proﬁbrotic markers and thus protected 
renovascular function as evidenced by attenuation of albuminuria 
and glomerular macrophage inﬁltration [ 32 –36 ]. Conversely, other 
studies reported endogenous Nox4 as a pivotal stabiliser of vascular 
integrity owing to its anti-apoptotic effects which seem to be medi- 
ated, in part, by activation of akonitase in various cell types including 
microvascular endothelial cells exposed to diabetic, ischaemic or in- 
ﬂammatory stress [ 37 –41 ]. Considering the alleged protective effects 
exerted by Nox4 itself, it is unlikely that its inhibition can contribute 
to apocynin-mediated BBB protection observed in this study. 
In contrast to other Noxs, Nox5 does not require p22-phox for acti- 
vation and is regulated in a Ca 2 + -sensitive manner [ 42 , 43 ]. Although 
the biological importance of vascular Nox5 is largely unknown, its 
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Fig. 7. Effects of protein kinase C- βI (PKC- βI ) gene knockdown on (A) transendothelial 
electrical resistance (TEER) ( n ≥ 3) and paracellular ﬂux of high and low molecular 
weight permeability markers, namely Evan’s Blue-labelled albumin ( n ≥ 3) (B) and 
sodium ﬂuorescein ( n ≥ 3) (C) across an in vitro model of human blood–brain barrier 
composed of human brain microvascular endothelial cells, astrocytes and pericytes 
in the absence or presence of PMA (100 nM, 4 h) or hyperglycaemia (HG; 25 mM d - 
glucose). Data are expressed as mean ± SEM from at least three different experiments. 


































































 involvement in endothelial cell proliferation and oxidative stress-
mediated atherosclerotic damage imply a putative role for this iso-
form diabetic cerebral barrier injury [ 44 , 45 ]. 
Hyperglycaemia-mediated activation of PKC represents a key
step in vasculopathies and is documented in organs that display
hyperglycaemia-mediated vascular leakage such as heart and retina
[ 46 , 47 ]. In keeping with these ﬁndings, stimulation of total PKC ac-
tivity in HBMEC (by PMA) increased the rates of apoptosis in this
study and consequently compromised the integrity and function ofan in vitro model of human BBB. Time-dependent increases in the
expression and activities of speciﬁc PKC isoforms have previously
been correlated with the severity of diabetic microvascular compli-
cations, endothelial barrier breakdown and apoptosis during cardiac
ischaemia [ 48 –50 ]. Naturally, suppression of PKC- α, PKC- β or PKC-
βII in the current study prevented BMEC apoptosis. This appeared to
be modulated in part by curtailment of NADPH oxidase activity deriv-
ing from reductions in its p22-phox and Nox2 subunits, membrane-
bound components that determine oxidase activity and stability and
O 2 
•− bioavailability. Decreased phosphorylation of cytosolic compo-
nents, notably p47-phox stemming from PKC inhibition may also con-
tribute to the diminished oxidase activity [ 14 ]. 
Increases in PKC- β and PKC- βII activities have been shown to ac-
count for much of the elevated total PKC activity in hyperglycaemic
HBMEC. However, despite abating total PKC activity, the inhibition of
PKC- βII failed to improve BBB integrity and conferred a critical role
on PKC- βI in this process and possibly in apoptosis [ 14 ]. Indeed, si-
lencing of PKC- βI gene in HBMEC supported this notion by radically
diminishing the levels of all apoptotic parameters in cells subjected to
hyperglycaemia. Concurrent suppressions of NADPH oxidase activity
and O 2 
•− release in the same cells reveal that PKC- βI acts upstream
to NADPH oxidase and regulation of oxidative stress is a crucial factor
in its barrier-protective effects. Since knockdown of PKC- βI failed to
normalise the PMA-evoked increases observed in caspase-3 / 7 activ-
ities despite preventing DNA fragmentation and Bax expression in
an efﬁcacious fashion, it is likely that other PKC isoforms and asso-
ciated downstream mechanisms possibly involving other Noxs may
also contribute to the regulation of endothelial cell apoptosis. In sup-
port of this notion, hyperglycaemia- and PMA-induced production of
O 2 
•− in human lung microvascular endothelial cells has recently been
ascribed to PKC- α-evoked activation of Nox5. Interestingly, while ge-
netic silencing of PKC-  also reduced PMA-stimulated Nox5 activity
in these cells, suppression of PKC- δ elevated activity [ 51 ]. Further-
more, activation of PKC- ζ by disturbed blood ﬂow has been shown to
induce endothelial apoptosis by modulating p53 and thus contribute
to the early events in atherosclerosis [ 52 ]. 
It is possible that other mechanisms such as hyperglycaemia-
induced activation of matrix metalloproteinases (MMPs) may also
be responsible for BMEC apoptosis similar to this reported in dia-
betic mice retinas [ 53 ]. Given that hyperglycaemia substantially in-
creases MMP-2 release in HBMEC through a process involving both
NADPH oxidase and PKC- β, this hypothesis warrants further investi-
gation [ 14 ]. Activation of small GTP-binding protein RhoA by high glu-
cose levels may also be implicated in hyperglycaemia-evoked HBMEC
apoptosis due to its roles in cytoskeletal reorganisation, proapoptotic
Bax expression and pro-survival phosphatidylinositol-3-kinase / Akt /
endothelial nitric oxide synthase pathway [ 54 , 55 ]. 
In conclusion, the present study reveals that hyperglycaemia per-
turbs BBB integrity, in part, through promotion of HBMEC apoptosis
by sequential activations of PKC and NADPH oxidase where target-
ing of PKC- βI may be of therapeutic value. Studies with PMA have
revealed that activation of PKC per se compromise endothelial cell vi-
ability and cerebral barrier integrity in equal measures and therefore
justify targeting of its speciﬁc isoform(s) as efﬁcacious therapeutic
options in negating hyperglycaemic barrier damage. Exploration of
growth proﬁle of cells that make up the BBB, notably HBMEC, as-
trocytes and pericytes in normal versus hyperglycaemic conditions
would be beneﬁcial in unravelling the precise contribution of each
cell line to hyperglycaemia-mediated BBB hyperpermeability. 
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